The Patent Eligibility and Restoration Act (PERA) would remove the current court-imposed restrictions on patent eligibility.

On September 24, 2024, the PTAB denied institution of a post-grant review proceeding initiated by Inari Agriculture, Inc. (Petitioner) against ...

Ex parte reexamination proceedings have been available for over 40 years. The reexamination statutes, Public Law 96-517 of July 1, 1981 (also known ...

It is well known that for an invention to be patentable, it must be ‘new’, even if the concept of what is new is not fully ...

CellTrust today announced that the company was victorious in the third-party challenge in front of the U.S. Patent and Trademark Office ("the USPTO") for claims of U.S. Patent No. 9,775,012 ("the ’012 ...

Congress is considering a bill that could exacerbate government waste and give American companies' most valuable trade ...

Prior art searches play a critical role in shaping effective scientific intellectual property strategies. This article, ...

Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L and petosemtamab monotherapy in 2/3L r/m HNSCC enrolling Petosemtamab in 2L+ r/m HNSCC interim clinical ...

There is no statutory bar in the US for patenting drug-device combinations, including drug transdermal/thermal patches. In the US, patents for methods of treatment are also allowed. A list of a few ...

Securing a patent can be tricky. The process is complex, and a single mistake can leave your client’s invention unprotected or entangled in legal disputes.

Lucy is a senior searcher, US patent agent, and qualified patent information professional who has previously worked in patent ...

VANCOUVER, BC / ACCESSWIRE / October 29, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce that it has initiated the nationalization ...